We Develop Pan Coronavirus Antivirals
HALO'S PROPRIETARY FREE FATTY ACID FORMULA IS A PAN CORONAVIRUS ANTIVIRAL
The pocket and antiviral mechanism we discovered are fully conserved in:
OUR PIPELINE & SCIENCE
INVESTMENT, LICENSING, AND PARTNERING
Halo Therapeutics is backed by experienced institutional and private investors. Key investors include the Development Bank of Wales, the KBA group and Science Angels Syndicate.
The Development Bank of Wales is a Welsh development bank that provides financial support for Welsh businesses and is owned by the Welsh Government. The bank provides loans for businesses to start up, strengthen and grow and also provides equity investments for already established businesses.
The KBA Group is an angel consortium of high net worth individuals co-led by Dr Nikolaos Kostopoulos and Paras Barot.
Science Angel Syndicate is a community of entrepreneurs and investors who source world class scientific discoveries that impact society on a global scale.
Please contact us for partnering, licensing, or investment opportunities in pan coronavirus antivirals and potential antiviral drugs for Covid-19.
As Omicron persists, consensus grows for abandoning the ancestral coronavirus strain to improve immune responses
XBB is expected to result in 40 million infections per week by the end of May before peaking at 65 million a month later. This comes nearly six months after Beijing dismantled its Covid Zero curbs, allowing the virus to spread rapidly among the country’s 1.4 billion residents.
Cardiff, Wales, 17 May 2023 – Clinical trials of an easy-to-use home therapeutic treatment for SARS- CoV-2 (coronaviruses) are underway following a £1.5 million investment led by the Development Bank of Wales alongside Science Angel Syndicate (SAS) members and the KBA Group.
Deborah Birx, a physician who served as former President Trump’s coronavirus response coordinator, said on Tuesday that the U.S. isn’t doing enough to prevent another pandemic like COVID-19.
The pandemic has progressed through a now-familiar pattern the past several months, with the latest variant — XBB.1.5 — infecting a lot of people in December and January before starting to fade
Three years after the start of the pandemic, SARS-CoV-2 shows no signs of settling into a seasonal pattern of spread, like influenza has.
COVID will eventually evade one of the few treatments for those infected and could cause deaths to ‘easily double,’ former White House advisor Deborah Birx says
During her time as White House COVID response coordinator under former President Donald Trump, from March 2020 through January 2021, Birx oversaw the development and widespread distribution of COVID tests, treatments, and vaccines.
Sir John Bell and Sir David King among leading scientists to argue UK is no better prepared than it was in 2020, as new variant in India causes concern
XBB.1.16 strain detected in 22 countries so far and is driving up infection rate in India
A new Covid sub-variant is causing some concern in the US, where it is spreading rapidly.
Some cases have also been recorded in the UK, so what do you need to know about XBB.1.5?
About 40% of confirmed U.S. Covid cases are caused by the XBB.1.5 strain, up from 20% a week ago.
What was it like to keep research work going during the worst of the pandemic? And how close are we to a vaccine that works against all current and future coronavirus variants?
Investigators at the University of Bristol and Biognos AB have identified a structural feature that distinguished the deadly coronavirus strains from harmless, common cold-causing variants. The findings, which were published in the Nov. 23, 2022
Scientists have discovered that a tailor-made pocket within the SARS-CoV-2 spike protein, which is capable of binding itself to the human cell surface, is what results in some coronaviruses causing severe disease.
The free fatty acid–binding pocket is a conserved hallmark in pathogenic β-coronavirus spike proteins from SARS-CoV to Omicron
Survey indicates that getting reinfected worsens symptoms of Long COVID or triggers a recurrence of symptoms in people who have recovered.
Descendants of Omicron are proliferating worldwide — and the same mutations are coming up again and again.
Some call it a swarm of variants — others refer to it as variant soup. Whatever it’s called, the current crop of immunity-dodging offshoots of the Omicron variant of SARS-CoV-2 is unprecedented in its diversity. This complexity makes it harder to predict coming waves of infection. It might even lead to a ‘double wave’ in some places, as first one variant and then another overtakes a population.
The OBN Awards, now in their 14th year, are a highly regarded and sought-after awards programme for the Life Sciences industry, designed to celebrate innovation and outstanding achievement across all corners of the life sciences industry.
As long as humans inhabit the earth, viruses will be part of life, and learning how to defend against novel coronaviruses will be vital for global health.
The surface proteins found on
both pathogens and host cells mediate cell
entry (and exit) and influence disease progression and transmission. Both types of proteins can bear host-generated posttranslational
There is a mixture of variants in circulation, and signs of vaccine fatigue in the population.
After two winters of Covid anguish, one would be forgiven for viewing the shortening of days with a sense of trepidation. It would not be entirely misplaced.
Rapidly escalating COVID-19 cases amid reduced virus surveillance forecasts a challenging autumn and winter in the WHO European Region
New WHO/Europe strategy urges countries to urgently address gaps in pandemic monitoring and response to avoid preventable deaths and severe disruptions to health systems
Halo co-founder and CSO Prof Imre Berger elected to the Fellowship of the Academy of Medical Sciences
Imre Berger, Professor of Biochemistry and Chemistry and Director of Bristol’s Max Planck Centre for Minimal Biology has been elected as a Fellow of the Academy of Medical Sciences for his outstanding contributions to biomedical science and notable discoveries during the COVID-19 pandemic.
Experts fear condition will hit people’s ability to work and have costs for employers and government, Jane Dalton writes
The U.S. Food and Drug Administration is continually monitoring how authorized and approved treatments for COVID-19 are affected by changing variants
A resurgence of Covid cases is under way across the UK, with infections in the over-70s at a record high and school leaders fearing that preparations
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews
COVID-19 can cause the brain to shrink and damage areas linked to memory and smell, says a new study by Oxford University that was published in the Nature journal
People suffering from COVID-19 could have several different SARS-CoV-2 variants hidden away from the immune system in different parts of the body, finds new research published in Nature Communications by an international research team. The study’s authors say that this may make complete clearance of the virus from the body of an infected person, by their own antibodies, or by therapeutic antibody treatments, much more difficult.
Oskar Staufer, Kapil Gupta, Jochen Estebano Hernandez Bücher, Fabian Kohler, Christian Sigl, Gunjita Singh, Kate Vasileiou, Ana Yagüe Relimpio, Meline Macher, Sebastian Fabritz, Hendrik Dietz, Elisabetta Ada Cavalcanti Adam, Christiane Schaffitzel, Alessia Ruggieri, Ilia Platzman, Imre Berger & Joachim P. Spatz
Imre Berger, Christiane Schaffitzel